CroíValve
PrivateLast Round
Series B
Jun 23, 2026
Total Funding Raised
$64.71M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
CroíValve operates in Healthcare & Life Sciences and is based in Dublin. Its latest recorded funding round was a Series B round in June 2026.
CroíValve is a medical device company developing a minimally invasive transcatheter valve system for the treatment of tricuspid regurgitation.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CroíValve Comparables
Compare CroíValve with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Coramaze Technologies | 90% | |
| Trisol Medical | 89% | |
| VDyne | 89% |
For institutional investors. Book with your work email.
CroíValve Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 23, 2026 | ||||
| Accelerator | Jul 2, 2025 | ||||
| Series B | Aug 7, 2024 | ||||
| Series A | Feb 4, 2022 | ||||
| VC Round | Sep 12, 2019 | ||||
Seed | Mar 28, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CroíValve Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Atlantic Bridge Capital | Series B, Series A, Seed |
| European Innovation Council Fund | Accelerator |
| Furthr VC | Series B |
| IAG Capital Partners | Series B |
| Ascentifi | Series B, Series A |
| BGF | Series B |
| Dublin Business Innovation Centre | Series B, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors increased 90% MoM.
- Sep 3, 2026
Grew 18% QoQ, from 50 to 59 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingNov 11, 2026
CroíValve Limited is developing a minimally invasive device to treat severe tricuspid regurgitation without open-heart surgery, in collaboration with CVRI Dublin’s Precise Core Lab, which assesses patients through imaging and advances AI-driven device matching.
- partners_withNov 11, 2026
On Nov 11th '26 in Ireland, CroíValve Limited collaborates with CVRI Dublin's Precise Core Lab to assess patients through imaging, advance AI-driven assessment, and match each patient with the most suitable device.
- is_developingSep 1, 2026
CroíValve Limited is developing the DUO Adapt System, a transcatheter approach that uses an adaptive coaptation valve to treat large tricuspid-regurgitation leaks without invasive surgery in Ireland on Sep 1st '26.
For institutional investors. Book with your work email.
CroíValve Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CroíValve's valuation, stock price, and market status.
Is CroíValve a public or private company?
CroíValve is a private company.
What is the current stock price of CroíValve?
CroíValve is a private company, so its shares have no public market price. Caplight tracks CroíValve's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CroíValve worth (valuation)?
Valuation information for CroíValve is not publicly available.
Can I buy CroíValve stock?
CroíValve shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CroíValve's last funding round?
CroíValve's most recent funding round was Series B on June 23, 2026.
Who are the main investors in CroíValve?
Key investors in CroíValve include Irrus Investments, The MedTech Syndicate.
Will CroíValve IPO soon?
No public IPO plans have been announced for CroíValve.
How can I track CroíValve secondary market activity?
Caplight tracks bids, offers, and trades in CroíValve's shares on secondary markets.